Health care partner Tom Bulleit (Washington, D.C.) was quoted in an article published July 15 by Bloomberg Law that examines the Trump administration’s international drug pricing plan.
Mr. Bulleit explains that the International Pricing Index policy could face challenges in court similar to the Trump administration’s most recent initiative to put prices of drugs in advertisements. He notes that lawsuits may claim the proposed IPI policy, which would affect tens of millions of Medicare beneficiaries, exceeds the government’s authority, arguing Congress needs to step in to change the drug payment formula.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.